Read All Retail Spotlights Read All Supplier Spotlights Read All Featured Content
Data Show Vectra Test Is Correlated with Treatment Response
DENVER, Oct. 19, 2018 (GLOBE NEWSWIRE) -- Centennial Resource Development, Inc. (“Centennial” or the “Company”) (NASDAQ: CDEV) announced today that it will report third quarter 2018 financial and operating results after the market closes for trading on November 5, 2018. Management will host an earnings conference call on November 6, 2018 at 8:00 a.m. Mountain (10:00 a.m. Eastern). Interested parties are invited to participate on the call by dialing (800) 789-3525, or (442) 268-1041 for international calls, (Conference ID: 2186036) at least 15 minutes prior to the start of the call or via the internet at www.cdevinc.com. A replay of the call will be available on Centennial’s website or by phone at (855) 859-2056 (Conference ID: 2186036) for a 14-day period following the call.
SANTA ANA, Calif., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”) today announced that it plans to release the Company's 2018 third quarter financial results after the market closes on November 5, 2018. Stephen G. Oswald, the Company’s chairman, president and chief executive officer, and Douglas L. Groves, the Company's vice president, chief financial officer and treasurer, will host a call that day, November 5, at 2:00 p.m. PT (5:00 p.m. ET) to review these results. To participate in the teleconference, please call 844-239-5278 (international 574-990-1017) approximately ten minutes prior to conference time. The participant passcode is 3893463. Mr. Oswald and Mr. Groves will speak on behalf of the Company and anticipate the meeting and Q&A period to last approximately 45 minutes.
JASPER, Ind., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Kimball, a subsidiary of Kimball International, Inc. (NASDAQ: KBAL) announced today that it has signed a definitive agreement to acquire substantially all the assets and assume certain specified limited liabilities of David Edward headquartered in Baltimore, Maryland. The closing is expected to be completed within the next 30 days, subject to customary closing conditions.
BRIDGEWATER, N.J., Oct. 19, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, announced today V-Go has launched and is now available in Italy through its previously disclosed exclusive distribution agreement with Movi SpA (“Movi”).
Retail Merchandiser Magazine
150 N. Michigan Ave., Suite 900
Chicago, IL 60601
312.676.1100
312.676.1101
